abstract |
Substituted heterocycle cyclohexylamines of Formula I and their pharmaceutically acceptable salts are described. The compounds of Formula I are antagonists of NMDA receptor channel complexes useful for treating vascular brain diseases such as for example cerebral ischemia, cardiac arrest, stroke and Parkinson's disease. |